Of­ten-passed plant in Col­orado has a new own­er, who's al­ready op­er­at­ing near­by

A man­u­fac­tur­ing fa­cil­i­ty in Long­mont, CO will have new oc­cu­pants soon.

AGC Bi­o­log­ics, a CD­MO with head­quar­ters in Den­mark, signed a pur­chase agree­ment to take over a cell and gene ther­a­py site that’s cur­rent­ly owned by No­var­tis.

No­var­tis leased the site from As­traZeneca just a lit­tle over a year ago, with the hopes of ramp­ing up man­u­fac­tur­ing for Zol­gens­ma, the con­tro­ver­sial gene ther­a­py for chil­dren younger than 2 years old with at­ro­phy. At the end of March, a No­var­tis spokesper­son said that the com­pa­ny would leave Long­mont by Ju­ly “at the lat­est,” which would leave 400 em­ploy­ees with­out a job. It was the sec­ond Col­orado plant the com­pa­ny had walked away from in the last four years, as it shut­tered Broom­field op­er­a­tions and cut 450 jobs over two years due to de­clin­ing sales.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER